Serbia is one of the fast growing emerging clinical trials markets in Europe. It has many advantages for conducting clinical studies:
- Clinical trial approval time takes up to 2 months.
- Rapid enrollment.
- Significant economic advantages.
- High site productivity.
- Significant clinical trial potential in major therapeutic areas.
- Advanced clinical infrastructure.
Smooth Drug Development provides CRO services in Serbia.